Viewing Study NCT02549313



Ignite Creation Date: 2024-05-06 @ 7:29 AM
Last Modification Date: 2024-10-26 @ 11:49 AM
Study NCT ID: NCT02549313
Status: COMPLETED
Last Update Posted: 2015-11-03
First Post: 2015-09-11

Brief Title: Effect of the Position of the Patients Head
Sponsor: Centre Hospitalier Universitaire de Saint Etienne
Organization: Centre Hospitalier Universitaire de Saint Etienne

Study Overview

Official Title: Study of the Effect of the Position of the Patients Head With Brain Lesions on Cerebral Blood Flow
Status: COMPLETED
Status Verified Date: 2015-11
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The position of the head of the patient influences the cerebral venous return and cerebral perfusion pressure CPP In our daily practice it is almost routine to prescribe a Trendelenburg position 30 in all brain-damaged patients However this is based only on precarious bibliographic databases It has been shown to decrease the Intracranial Pressure ICP in Trendelenburg position relative to the horizontal with varying effects on PPC Effects on sylvian objectified by Doppler velocities and cerebral oxygenation seem unaffected by changes of position of the head of the patient But the whole of the literature on this subject has significant bias
Detailed Description: Registration of blood flow changes induced when the patients head will be tilted at 0 that is to say flat 15 and 30 the order of actions will be determined by randomization The patient will remain 10 minutes in each of these positions and will also have a little extra blood sample of 1 ml ie 9 samples These measures will be carried out again the next day and then after five days to see if the results vary depending on the evolution of his condition

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
2011-A01565-36 OTHER ANSM None